Journal of the American Chemical Society · 2006 · 45 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAntimicrobial PeptidesNatural Product-based Drug DesignNonribosomal Peptide BiosynthesisPeptide ChemistryPeptide Drug DiscoveryPeptide ProdrugsBactericidal AgentsCyclic Peptide DesignHeterocyclic LigandsNatural Product Inspired PeptidomimeticsNonribosomal Peptide AntibioticsPeptide Chain ElongationRational DesignSynthetic Antimicrobial Peptide Design
Heterocycles display common structural motifs in nonribosomally produced peptides with an enormous impact on their bioactivity. In the case of the branched cyclic Bacitracin A, the thiazoline moiety is manufactured during NRPS peptide chain elongation. Here we describe a method to selectively alter the heterocyclic metal binding subunit of Bacitracin A by the synthesis of heterocyclic building blocks that were successfully coupled to the linear decapeptide and subsequently cyclized using the excised bacitracin PCP-TE bidomain. Utilization of this cyclase allowed the first generation of branched cyclic bacitracin derivatives containing thiazole and oxazoles. The generated bacitracin derivatives showed bactericidal activity, indicating the possibility of altering the biological important heterocyclic subunit and overcoming existing limitations for the application of bacitracin.
25
Dirk Konz, Andrea Klens, Kurt Schörgendorfer et al. · Chemistry & Biology · 1997 · 221 citations · Full text
Yasumasa Hamada, Makoto Shibata, Tsuneyuki Sugiura et al. · The Journal of Organic Chemistry · 1987 · 203 citations
Natural Sciences, Chemistry, Natural Product Biosynthesis +9